Full-Time

Medical Editor

Posted on 9/8/2025

Inizio Engage

Inizio Engage

501-1,000 employees

Provides integrated data insights for pharma

No salary listed

Manchester, UK

Hybrid

This is a hybrid remote/in-office role.

Category
Medical, Clinical & Veterinary (2)
,
Requirements
  • Experience editing in the medical communications, pharmaceutical or healthcare sector (minimum 1 year)
  • Proficiency in multiple software including MS Word, PowerPoint, and Adobe
  • Excellent written English, including knowledge of UK and US nuances
  • Be able to perform editorial tasks such as copy edits, proof reviews and quality checking; experience in fact checking is beneficial
  • Experience working across several accounts/projects whilst maintaining meticulous attention to detail
Responsibilities
  • Editorial Services
  • Complete all editorial tasks to an excellent standard: + Copy edit: ensure linguistic accuracy, consistency and clarity following project briefs; work to/update style guides in light of any client/team preferences, including styling references and layout formatting where required + Proof review: cross-check work across different outputs, contexts and formats, collaborating with studio to ensure content is correct + Quality check: review copy for spelling, grammar, punctuation and overall sense + Fact check:verify scientific claims are substantiated within manuscripts, and that references are cited/marked up * Work with account teams to guarantee a wider understanding of the therapy/industry area and account is reflected in our quality process; provide a true 'value' for clients dates wherever possible * Begin to provide healthcare compliance support to team members; provide dedicated reviews and offer guidance around regulations and other codes where relevant * Represent the Editorial team outside of your account work; build relationships with teams across the business, providing account support **Time Management** * Communicate with team members (and wider company) to manage workload – confirm timelines and scope to ensure project expectations are kept up to date * Promote the need to obtain clear briefs and scope of work from both clients and colleagues; start to build relationships with freelance * You will monitor your own capacity, planningaround multiple delivery requirements and conflicting deadlines * Respond to excess workload, work with Operations to book and allocate freelance resource * Assist our teams in monitoring time on job; notify the team of scope creep; strengthen understanding in budget and timescales * Understand and use platforms and internal systems (e.g. Smartsheet)
Desired Qualifications
  • Knowledge of UK pharmaceutical regulations (such as the ABPI Code) and working within a communications agency would be advantageous
  • Bachelor's degree in life science, English, journalism or other relevant subject is a bonus

Inizio Engage turns scattered data into integrated insights and learning solutions for the pharmaceutical and biotechnology sectors. Its PROPENSITY4 data platform combines data from multiple sources to support decision making across customer needs, commercial operations, and strategic goals. The ecosystem includes Ashfield Excellence Academy, Axiom, Cormis, and Logicearth, which provide training, communications, and capability-building programs for pharma commercial and medical teams. By pairing data analytics with targeted training and talent development, the company helps patients, healthcare professionals, and pharmaceutical firms improve outcomes and gain competitive advantages.

Company Size

501-1,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Upper Dublin Township, Pennsylvania

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • Nazaré Access Academy addresses growing US patient access complexity for pharma.
  • PROPENSITY4 transforms disparate data into integrated insights for commercial optimization.
  • Strategic leadership appointments signal potential for streamlined operations and market expansion.

What critics are saying

  • Nazaré brand consolidation cannibalizes legacy divisions' revenue within 6-12 months.
  • IQVIA's integrated platforms directly compete with PROPENSITY4's data analytics services.
  • AI-powered learning platforms displace human-led training, halving demand by 2028.

What makes Inizio Engage unique

  • End-to-end commercialization partner spanning discovery through post-launch lifecycle.
  • Integrated suite connecting medical affairs, data insights, and creative engagement capabilities.
  • 5,000+ professionals across 20+ countries delivering localized pharmaceutical expertise globally.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Private Medical Insurance

Life Insurance

Pension Scheme

Hybrid Work Options

Paid Vacation

401(k) Retirement Plan

Company News

PMLiVE
Dec 11th, 2025
Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series

Inizio Engage CEO Jim Sage featured in pharmaphorum's "12 Questions" series. Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. We're pleased to share that Jim Sage, Global CEO and President of Inizio Engage, has been featured in pharmaphorum's latest "12 Questions" interview series. In the conversation, Jim reflects on his career across international markets, his motivations as a leader, and the experiences that have shaped his approach to building high-performing teams. He also explores some of the most pressing challenges facing the pharmaceutical industry today, including pricing pressures, launch performance, and the need for new reimbursement models. Jim highlights how data, technology, and AI are already transforming the way organisations operate, and discusses the growing importance of patient-centric approaches, from HUB services to personalised support throughout the treatment journey. This content was provided by Inizio Discover Jim Sage's insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum "12 Questions" interview. As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek(R) 2025 in Atlanta, experts from across Inizio reflected... Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making. Inizio today announced the launch of InConcert(TM), a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle. Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders. As the global hematology community prepares for the 67th ASH(R) Annual Meeting and Exposition, Inizio experts share their perspectives on what's driving the field forward - and how pharma companies... At Inizio Medical, we believe AI isn't replacing Medical Affairs - it's redefining what's possible. Our platform, iON.AI(TM), enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless... Discover how Inizio experts are shaping the future of obesity care - where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact. At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact - discover how this human-centered innovation is defining the... Inizio is leading the way in Intelligent Commercialization(TM) by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization. * 1 * 2 * 3 * 4 * 5 * 6 * 7 * 8 * 9 * 10 * 11 * 12 * 13 * 14 * 15 * 16 * 17 * 18 * 19 * 20 * 21 * 22 * 23 * 24 * 25 * 26 * 27 * 28 * 29 * 30 * 31 * 32 * 33 * 34 * 35 * 36 * 37 * 38 * 39 * 40 * 41 * 42 * 43 * 44 * 45 * 46 * 47 * 48 * 49 * 50

PMLiVE
Sep 24th, 2025
Inizio celebrates six finalist honors at the 2025 PM360 Trailblazer Awards

We're proud to announce that our teams across Inizio Evoke, Inizio Engage, and Inizio Medical have been named finalists in six prestigious categories at the 2025 PM360 Trailblazer Awards, which recognize excellence and innovation in healthcare marketing.

Bdaily
Sep 14th, 2025
Inizio names new chief executive

Inizio, a global commercialisation partner to health and life sciences companies, has appointed Ryan Quigley as chief executive.

Inizio Engage
Mar 5th, 2025
Inizio Engage choose Egg as Patient Support Program implementation partner in Italy.

After a review of potential Patient Support Program (PSP) partners in Italy, Inizio Engage has formed a collaboration with Egg, head quartered in Milan.

Haymarket Media
Feb 12th, 2025
The Escalator: Pfizer, Vertex Pharmaceuticals, Inizio and more

Inizio announced that Remco op den Kelder has been appointed to the president of Inizio Advisory and Jim Sage will become president of Inizio Engage.

INACTIVE